OneTeam™: Setting A New Standard for Biotech Program Visibility

Less Risk, More Speed -The New Blueprint For Bioconjugate Development

Flexible Therapeutic Development: Balancing Speed, Cost, and Process

Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development

How AI-Enabled Validation Technologies Enable The Predictive Plant

Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems

Translating Stem Cell Programs To GMP

Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right

Integrated Thinking for Complex FIH Programs

Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs

Selecting A Prefillable Syringe System With Confidence

Designing Drug Substance Processes For Fill-Finish Compatibility

Meeting The Challenge Of Rising API Complexity

Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology

AI Based Screening And Selection Of Co-Formers For Co-Crystallization

Simultaneous Spray Drying: Dry Powder Inhaler Combination Formulations

Cambrex Scientist Spotlight: Daniel Kirschner

How To Deal With The Complexity Of Drugs In Clinical Development

Managing Nitrite Impurities: Supplier-Manufacturer View

Expanding The OSD Toolbox

Taste Masking 101: Sensory And Performance Evaluation

Developing Long-Acting Contraceptive Injectables

Discovering A Unique Multimillion Euro Nanotechnology Facility

Cambrex Scientist Spotlight: TJ Harper

Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

Explore What's Next: Product Characterization

Sustainable Approaches To Oligonucleotide Manufacturing

Optimizing Monoclonal Antibody Manufacturing For Commercial Success

Evaluating Viral Clearance For Continuous Processes

How Molecular Structure Influences Potency Of A Therapeutic Biologic

How Biosafety Assurance Can Be Both Rapid And Purposeful

A Rapid, Innovative Approach To Release Testing

GMP-Focused Platform Processes For Microbial, pDNA, And mRNA

Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS

Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service

Advancing Viral Vector Manufacturing: The Importance Of The Cell Line

Minaris Advanced Therapies Capabilities Update March 2026: Cell & Gene Therapy

Lonza Capabilities Update March 2026: Cell & Gene Therapy

Landmark Bio Capabilities Update March 2026: Cell & Gene Therapy

Comprehensive Cell Solutions Capabilities Update March 2026: Cell & Gene Therapy

Cytovance Biologics Capabilities Update March 2026: Large Molecule

ElevateBio Capabilities Update March 2026: Cell & Gene Therapy

Quotient Sciences Capabilities Update March 2026: Small Molecule Drug Product

Pfizer CentreOne Capabilities Update March 2026: Small Molecule Drug Product

PCI Pharma Services Capabilities Update March 2026: Small Molecule Drug Product

Mikart Capabilities Update March 2026: Small Molecule Drug Product

Asymchem Capabilities Update March 2026: Small Molecule Drug Product

SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance

Step Inside One Of America's Leading Protein Biologics CDMO Sites

Explore What's Next: Product Characterization

Storing Your Banks With Ease And Confidence

GMP-Focused Platform Processes For Microbial, pDNA, And mRNA

Rising To Meet Increasing Demand For Microbial Based Biologics

Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service

GLP And The Impact To Start Up Companies

Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing

Discovering A Unique Multimillion Euro Nanotechnology Facility

The Future Of QC: Robotics And Automation

Your Digital QC Companion For Sterility Testing

Defining Clinical Supply Resilience

The Reality of AI in Clinical Supplies

Becoming a Client of Choice for CDMOs

The Recovery Playbook for Site Disruptions

Pandemic Lessons and Vendor Partnerships

Clinical Supply Chain Therapy: Lowering Risk (And Your Blood Pressure)

The One Quality Metric That Actually Matters

Navigating Private Equity Ownership In The CDMO Space

What Great CDMO Selection Looks Like In 2026

The "Bad News" Stress Test: How CDMOs Handle Escalation

The BioSecure Act And Unfiltered Supply Chain Realities

The Unfiltered Truth About CDMO Selection

Consistent, Reliable, High-Quality Components

Workforce Challenges Key To Outsourcing

Selecting A CDMO: A Guide To Successful Collaboration

Visionary Thinkers And Problem Solvers: The Cambrex Team

Collaborating To Craft Efficient Processes

Delivering Top Quality Fill Finish Manufacturing

Managing Multiple Partners – And Materials – From Around The Globe

Fostering CDMO Collaboration On Both Sides

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

BoB@JPM: Ron Cooper, enGene

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

Engineering B Cells With Immusoft's Sean Ainsworth

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Biotech Funding And IPO Temperature Check With CREATE Medicine's Allan Shaw

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

The Generalist Biotech CEO With Seekyo's Oury Chetboun

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

Proactive Procurement Strategies For Biotech With Tom Wells

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

Biotech Angel Investing With Yaniv Sneor

Leading A tRNA Startup With Alltrna's Michelle Werner

Executing A Product Pivot With Vir's Mark Eisner, MD

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

The Implications Of China's Growing Biotech Industry With Allan Shaw

How To Be A CFO With Insmed's Sara Bonstein

Deal And Investment Trends With Investment Banker David Sans

Business of Biotech 2.0 with Ben Comer

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

BoB@JPM: Kasper Roet, Ph.D., QurAlis

BoB@JPM: Rick Modi, Affinia Therapeutics

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

BoB@JPM: Tom Chalberg, Ph.D., Genascence

BoB@JPM: Ran Zheng, Landmark Bio

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

High-Throughput Discovery With BIOPTIC's Andrey Dobry

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

Biotech Story Time With Tal Zaks, M.D. (Part 2)

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

Biotech Story Time With Tal Zaks, M.D. (Part 1)

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

Biopolitics With Allan Shaw

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

Biotech C-Suite Construction With Allan Shaw

The Peptide Promise With NervGen's Mike Kelly

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

Embracing Biotech Chaos With Memo's Erik van den Berg

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

Steering Through Setbacks with AVEO Oncology's Michael Bailey

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

Expanding The Proteome with ProFound's John Lepore, M.D.

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

First AI Antibody In Humans with Aulos' Aron Knickerbocker

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

Topical Ocular Biologics with Claris Bio's Clarke Atwell

True DEI Value in Biopharma with Arcellx's Rami Elghandour

How Daiichi Sankyo Revitalized ADCs

Mission-Driven Dementia Funding with DDF's Jonathan Behr

How Is Mythic Therapeutics Transforming The ADC Space?

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

What's Next For Ampersand Biomedicines?

Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous

Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies' Paul Romness

Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes

Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz

The Editors' Roundtable: A 2025 Retrospective of the Life Sciences Industry

Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki

Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.

Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay